RefolkCandidates

Parabilis Medicines

parabilismed.com · 172 people

Open roles
14
Remote
0
Headcount
172
Offices
1

About Parabilis Medicines

Parabilis Medicines™ is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for people living with cancer. Through our pioneering Helicon™ discovery platform, Parabilis is engineering precisely-tuned, stabilized helical peptide therapeutics that have the potential to unlock a large number of traditionally undruggable targets. FOG-001, our first-in-class TCF-blocking β-catenin inhibitor and lead clinical program, is being evaluated in a Phase 1/2 study for patients with colorectal cancer and other solid tumors and is proof of the applicability of our platform to address undruggable intracellular protein-protein targets. We are additionally advancing a pipeline of other first-in-class programs that target proteins known to be relevant to numerous cancers, but considered intractable with traditional drug modalities. The versatility of the Helicon approach allows for the discovery of multiple targeting mechanisms, including functional protein-protein interaction inhibitors, bifunctional degraders, and radioligand therapeutics. We are headquartered in Cambridge, Mass., and are well-capitalized, with more than $500 million raised to date from leading life sciences investors. For more information, please visit: www.parabilismed.com

Markets

Biotech/Pharma

Offices

Cambridge, Massachusetts

Backed by

Foresite CapitalGV

Open roles at Parabilis Medicines

Apply on autopilot

Tell me once what you are looking for. Every morning I rank the whole catalog against your profile, pick the openings worth your time, and prepare a tailored resume and cover letter for each one.

Applications finish as drafts. Nothing is sent until you read it and press send. New accounts start with 500 free credits.

Counted from the job board Parabilis Medicines publishes. Refolk is not affiliated with Parabilis Medicines and does not handle their hiring.